Fourway Pharmacy Limited - Accounts to registrar (filleted) - small 18.2

Fourway Pharmacy Limited - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v20.4.0.470 04759489 Board of Directors Board of Directors 1.6.19 31.5.20 31.5.20 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure047594892019-05-31047594892020-05-31047594892019-06-012020-05-31047594892018-05-31047594892018-06-012019-05-31047594892019-05-3104759489ns16:EnglandWales2019-06-012020-05-3104759489ns15:PoundSterling2019-06-012020-05-3104759489ns11:Director12019-06-012020-05-3104759489ns11:Director22019-06-012020-05-3104759489ns11:PrivateLimitedCompanyLtd2019-06-012020-05-3104759489ns11:SmallEntities2019-06-012020-05-3104759489ns11:AuditExempt-NoAccountantsReport2019-06-012020-05-3104759489ns11:SmallCompaniesRegimeForDirectorsReport2019-06-012020-05-3104759489ns11:SmallCompaniesRegimeForAccounts2019-06-012020-05-3104759489ns11:FullAccounts2019-06-012020-05-3104759489ns11:OrdinaryShareClass12019-06-012020-05-3104759489ns11:RegisteredOffice2019-06-012020-05-3104759489ns6:CurrentFinancialInstruments2020-05-3104759489ns6:CurrentFinancialInstruments2019-05-3104759489ns6:ShareCapital2020-05-3104759489ns6:ShareCapital2019-05-3104759489ns6:RetainedEarningsAccumulatedLosses2020-05-3104759489ns6:RetainedEarningsAccumulatedLosses2019-05-3104759489ns6:PlantMachinery2019-06-012020-05-3104759489ns6:LeaseholdImprovements2019-05-3104759489ns6:PlantMachinery2019-05-3104759489ns6:FurnitureFittings2019-05-3104759489ns6:ComputerEquipment2019-05-3104759489ns6:LeaseholdImprovements2019-06-012020-05-3104759489ns6:FurnitureFittings2019-06-012020-05-3104759489ns6:ComputerEquipment2019-06-012020-05-3104759489ns6:LeaseholdImprovements2020-05-3104759489ns6:PlantMachinery2020-05-3104759489ns6:FurnitureFittings2020-05-3104759489ns6:ComputerEquipment2020-05-3104759489ns6:LeaseholdImprovements2019-05-3104759489ns6:PlantMachinery2019-05-3104759489ns6:FurnitureFittings2019-05-3104759489ns6:ComputerEquipment2019-05-3104759489ns6:CurrentFinancialInstrumentsns6:WithinOneYear2020-05-3104759489ns6:CurrentFinancialInstrumentsns6:WithinOneYear2019-05-3104759489ns11:OrdinaryShareClass12020-05-3104759489ns6:RetainedEarningsAccumulatedLosses2019-05-3104759489ns6:RetainedEarningsAccumulatedLosses2019-06-012020-05-31
REGISTERED NUMBER: 04759489 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MAY 2020

FOR

FOURWAY PHARMACY LIMITED

FOURWAY PHARMACY LIMITED (REGISTERED NUMBER: 04759489)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 May 2020










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


FOURWAY PHARMACY LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 May 2020







DIRECTORS: T O Amesimeku
C B Fernandes





REGISTERED OFFICE: Thames House, 2nd Floor
3 Wellington Street
Woolwich
London
SE18 6NY





REGISTERED NUMBER: 04759489 (England and Wales)





ACCOUNTANTS: Richmond Gatehouse LLP
Thames House, 2nd floor
3 Wellington Street
London
SE18 6NY

FOURWAY PHARMACY LIMITED (REGISTERED NUMBER: 04759489)

BALANCE SHEET
31 May 2020

2020 2019
Notes £    £   
FIXED ASSETS
Tangible assets 4 34,848 42,943

CURRENT ASSETS
Stocks 92,154 86,662
Debtors 5 318,829 649,139
Cash at bank and in hand 60,934 89,118
471,917 824,919
CREDITORS
Amounts falling due within one year 6 (208,890 ) (219,142 )
NET CURRENT ASSETS 263,027 605,777
TOTAL ASSETS LESS CURRENT
LIABILITIES

297,875

648,720

CAPITAL AND RESERVES
Called up share capital 7 100 100
Retained earnings 8 297,775 648,620
SHAREHOLDERS' FUNDS 297,875 648,720

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2020.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2020 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 26 February 2021 and were signed on its behalf by:




T O Amesimeku - Director



C B Fernandes - Director


FOURWAY PHARMACY LIMITED (REGISTERED NUMBER: 04759489)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 May 2020


1. STATUTORY INFORMATION

Fourway Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 20% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 5 (2019 - 5 ) .

FOURWAY PHARMACY LIMITED (REGISTERED NUMBER: 04759489)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 May 2020


4. TANGIBLE FIXED ASSETS
Improvements Fixtures
to Plant and and Computer
property machinery fittings equipment Totals
£    £    £    £    £   
COST
At 1 June 2019
and 31 May 2020 30,457 4,088 77,470 18,680 130,695
DEPRECIATION
At 1 June 2019 17,828 2,845 50,417 16,662 87,752
Charge for year 2,032 248 5,411 404 8,095
At 31 May 2020 19,860 3,093 55,828 17,066 95,847
NET BOOK VALUE
At 31 May 2020 10,597 995 21,642 1,614 34,848
At 31 May 2019 12,629 1,243 27,053 2,018 42,943

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2020 2019
£    £   
Trade debtors 127,073 67,511
Amounts owed by group undertakings 148,186 538,788
Other debtors 43,570 42,840
318,829 649,139

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2020 2019
£    £   
Trade creditors 155,402 178,017
Taxation and social security 42,815 40,411
Other creditors 10,673 714
208,890 219,142

7. CALLED UP SHARE CAPITAL


Allotted, issued and fully paid:
Number: Class: Nominal 2020 2019
value: £    £   
100 Ordinary 1 100 100

8. RESERVES
Retained
earnings
£   

At 1 June 2019 648,620
Profit for the year 149,155
Dividends (500,000 )
At 31 May 2020 297,775

FOURWAY PHARMACY LIMITED (REGISTERED NUMBER: 04759489)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 May 2020


9. RELATED PARTY DISCLOSURES

During the year, a dividend of £500,000 was voted to Alexxar Limited.

10. ULTIMATE CONTROLLING PARTY

The company is controlled by the directors.